
JACC: Heart Failure – A Leading Source in Cardiovascular Research and Clinical Practice
JACC: Heart Failure, a peer-reviewed journal published by the American College of Cardiology (ACC), stands at the forefront of cardiovascular medicine, specializing in all aspects of heart failure research and treatment. As part of the prestigious Journal of the American College of Cardiology (JACC) family, JACC: Heart Failure offers in-depth insights, cutting-edge research, and clinical guidance to cardiologists, researchers, and healthcare professionals globally.
JACC: Heart Failure is dedicated to advancing the understanding and management of heart failure, from pathophysiology to treatment and prevention. The journal covers a wide spectrum of topics, including:
Heart failure with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF)
Acute and chronic heart failure
Device therapy and mechanical circulatory support
Cardiomyopathies and right heart failure
Heart transplantation and advanced heart failure therapies
Biomarkers, imaging, and diagnostic advances
Clinical trials, epidemiology, and outcomes research
The journal provides a platform for original research articles, reviews, expert commentaries, clinical case studies, and perspectives that shape the practice of heart failure care.
JACC: Heart Failure is recognized for its high impact factor and is indexed in major databases like PubMed, Scopus, and Web of Science. The journal attracts submissions from leading researchers and clinicians worldwide, reflecting its authoritative position in the cardiovascular field.
Its editorial board includes internationally renowned experts who ensure rigorous peer-review and uphold the highest standards of scientific integrity. As a result, JACC: Heart Failure is frequently cited in clinical guidelines, policy documents, and educational resources.
Heart failure research journal
JACC Heart Failure articles
ACC heart failure publication
Cardiovascular disease journals
Heart failure treatment guidelines
Clinical trials in heart failure
Top heart failure journal
The global burden of heart failure continues to rise, affecting over 64 million people worldwide. With its comprehensive approach to all facets of heart failure, JACC: Heart Failure plays a critical role in educating clinicians, informing research, and improving patient outcomes. Its publications guide evidence-based care and promote the translation of scientific discovery into clinical innovation.
JACC: Heart Failure offers both subscription-based and open access options, increasing the visibility and accessibility of its content. Articles are published online ahead of print, ensuring timely dissemination of the latest developments.
JACC: Heart Failure – Advancing Research and Innovation in Heart Failure Care
JACC: Heart Failure is a premier peer-reviewed medical journal dedicated exclusively to the study and management of heart failure. Published by the American College of Cardiology (ACC), the journal serves as a vital resource for clinicians, researchers, and healthcare professionals focused on improving the lives of patients suffering from heart failure, one of the leading causes of hospitalization and mortality worldwide.
Launched as part of the Journal of the American College of Cardiology (JACC) family, JACC: Heart Failure delivers cutting-edge research, clinical insights, and evidence-based practices related to all aspects of heart failure. From novel therapeutic strategies to diagnostic tools and patient-centered care models, the journal covers a wide range of topics that reflect the evolving landscape of cardiology.
With a strong emphasis on both clinical and translational research, JACC: Heart Failure publishes original investigations, comprehensive reviews, editorials, and case reports that help bridge the gap between scientific discovery and clinical application. The journal’s content is rigorously peer-reviewed and curated by leading experts in the field.
Heart failure is a complex syndrome that affects millions globally and poses significant challenges to patients and healthcare systems alike. As new therapies and technologies emerge, clinicians need access to reliable, up-to-date information to guide treatment decisions and improve patient outcomes. JACC: Heart Failure addresses this need by providing high-quality, evidence-based content that reflects the latest scientific advancements.
The journal’s impact factor and growing readership make it a trusted source within the cardiovascular community. It plays a key role in shaping clinical guidelines and informing policy decisions related to heart failure care.
JACC: Heart Failure features research and clinical studies on a wide array of heart failure-related topics, including:
Acute and chronic heart failure management
Advanced heart failure therapies, including mechanical circulatory support and transplantation
Pharmacological and device-based treatments
Biomarkers and imaging techniques
Patient quality of life and outcomes
Health disparities and global perspectives on heart failure
Preventive strategies and risk reduction
Precision medicine and personalized care approaches
This wide-ranging scope ensures that the journal remains at the forefront of cardiology research and is highly relevant to healthcare professionals worldwide.
JACC: Heart Failure is available both online and in print. Subscribers can access full-text articles through the JACC.org platform, which also offers search tools, article collections, and multimedia content like podcasts and expert interviews. Many articles are open access, ensuring that critical information is readily available to the broader medical community.
Scope of JACC: Heart Failure – Advancing Research in Cardiovascular Care
JACC: Heart Failure is a premier peer-reviewed journal under the umbrella of the Journal of the American College of Cardiology (JACC). As a dedicated platform for the latest developments in heart failure, the journal serves as a critical resource for clinicians, researchers, and healthcare professionals worldwide. Its scope encompasses all aspects of heart failure, from pathophysiology and diagnosis to innovative therapies and clinical outcomes.
The primary scope of JACC: Heart Failure includes high-quality original research that advances the understanding and treatment of heart failure. The journal covers a broad range of topics, such as:
Epidemiology and Risk Stratification
Studies analyzing the prevalence, incidence, and risk factors associated with heart failure, aiming to enhance early detection and prevention.
Basic and Translational Science
Groundbreaking research that uncovers the molecular and cellular mechanisms of heart failure, facilitating the development of targeted therapies.
Clinical Trials and Therapeutic Strategies
Reports on randomized clinical trials, observational studies, and real-world data that evaluate pharmacologic and device-based interventions.
Advanced Heart Failure and Transplantation
Research addressing mechanical circulatory support, heart transplantation, and end-of-life care in patients with advanced heart failure.
Imaging and Diagnostics
Innovations in cardiac imaging, biomarkers, and diagnostic tools that support early and accurate diagnosis.
JACC: Heart Failure emphasizes clinical applicability and global relevance. The journal encourages submissions that address disparities in care, global health trends, and emerging challenges in the management of heart failure across diverse populations.
It also highlights state-of-the-art reviews, editorials, and clinical perspectives that synthesize current knowledge and guide best practices in heart failure care.
The scope of the journal fosters collaboration across disciplines, bridging the gap between cardiology, internal medicine, surgery, pharmacology, and public health. With a commitment to publishing timely and impactful research, JACC: Heart Failure supports innovation and evidence-based care models to improve patient outcomes.
High Visibility and Impact Factor
The journal boasts a high impact factor, ensuring that research published within it reaches a wide audience and garners significant citations.
Rigorous Peer Review
Each submission undergoes a meticulous review process by leading experts in the field, ensuring scientific integrity and clinical relevance.
Global Readership
As part of the JACC family, the journal reaches cardiologists, healthcare providers, and researchers across the globe.